RNA-seq with TOP2-RNA was performed to detect mutations in glioma-related genes, oncogenic fusion genes, and gene overexpression (defined as > average + 3 standard deviation) for receptor tyrosine kinase (TK) (Supplementary Data 2). This evidence concerns the gene NTRK1 and glioma.